[
  {
    "ts": "2026-01-09T12:23:30+00:00",
    "headline": "J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts",
    "summary": "The New Jersey pharma will now offer some of its branded medicines on the US government-created DTC platform, TrumpRx.gov.",
    "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-mfn-drug-pricing-deal-branded-medicines/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "ff0d069b-ad61-3460-9dea-e4701a72a4c0",
      "content": {
        "id": "ff0d069b-ad61-3460-9dea-e4701a72a4c0",
        "contentType": "STORY",
        "title": "J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts",
        "description": "",
        "summary": "The New Jersey pharma will now offer some of its branded medicines on the US government-created DTC platform, TrumpRx.gov.",
        "pubDate": "2026-01-09T12:23:30Z",
        "displayTime": "2026-01-09T12:23:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/ef8ecfc6a5e4a78b276c45c9abb797cc",
          "originalWidth": 1024,
          "originalHeight": 700,
          "caption": "Johnson & Johnson has inked a drug pricing deal with the White House",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VzpCekl2eIipOcsoKH7yMQ--~B/aD03MDA7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/ef8ecfc6a5e4a78b276c45c9abb797cc.cf.webp",
              "width": 1024,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wtqFOx9uBfrdnx.jAIRW4Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/ef8ecfc6a5e4a78b276c45c9abb797cc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-mfn-drug-pricing-deal-branded-medicines/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-cuts-mfn-deal-122330905.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T14:10:00+00:00",
    "headline": "Enhanced Genomics Appoints Dr Katerina Leftheris to Its Board of Directors",
    "summary": "CAMBRIDGE, England, January 09, 2026--Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced Katerina Leftheris, Ph.D. has joined its Board of Directors. Katerina’s appointment as a Director forms part of the Company’s ongoing strategy to expand its internal therapeutics pipeline for drug targets identified using its 3D multi-omics platform.",
    "url": "https://finance.yahoo.com/news/enhanced-genomics-appoints-dr-katerina-141000705.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6139a2ef-c9bd-3902-aa7b-8be2968d9c12",
      "content": {
        "id": "6139a2ef-c9bd-3902-aa7b-8be2968d9c12",
        "contentType": "STORY",
        "title": "Enhanced Genomics Appoints Dr Katerina Leftheris to Its Board of Directors",
        "description": "",
        "summary": "CAMBRIDGE, England, January 09, 2026--Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced Katerina Leftheris, Ph.D. has joined its Board of Directors. Katerina’s appointment as a Director forms part of the Company’s ongoing strategy to expand its internal therapeutics pipeline for drug targets identified using its 3D multi-omics platform.",
        "pubDate": "2026-01-09T14:10:00Z",
        "displayTime": "2026-01-09T14:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/92a18962282835085893daa5bca44252",
          "originalWidth": 1060,
          "originalHeight": 361,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pfdmAo4NJwBpNNs_bcEAkg--~B/aD0zNjE7dz0xMDYwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/92a18962282835085893daa5bca44252.cf.webp",
              "width": 1060,
              "height": 361,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lF0bGFkby3nxzHWvrptO9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/92a18962282835085893daa5bca44252.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/enhanced-genomics-appoints-dr-katerina-141000705.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/enhanced-genomics-appoints-dr-katerina-141000705.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PLRX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]